Zobrazeno 1 - 10 of 321 pro vyhledávání: '"Craig S. Sauter"'
2
Akademický článek
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy
Autor: Danai Dima, Al-Ola Abdallah, James A. Davis, Hussein Awada, Utkarsh Goel, Aliya Rashid, Shaun DeJarnette, Faiz Anwer, Leyla Shune, Shahzad Raza, Zahra Mahmoudjafari, Louis Williams, Beth Faiman, Joseph P. McGuirk, Craig S. Sauter, Nausheen Ahmed, Jack Khouri, Hamza Hashmi
Publikováno v: Blood Cancer Journal, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract The presence of extramedullary disease (EMD) has been associated with poor outcomes in patients with relapsed-refractory multiple myeloma (RRMM). Herein, we report the outcomes of RRMM patients who were treated with standard-of-care (SOC) ch
Externí odkaz: https://doaj.org/article/4d4e0e6e0fe64208a7cce810ec77ca4d
Zobrazit plný text záznamu
3
Akademický článek
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
Autor: Susan E. Prockop, Aisha Hasan, Ekaterina Doubrovina, Parastoo B. Dahi, Irene Rodriguez-Sanchez, Michael Curry, Audrey Mauguen, Genovefa A. Papanicolaou, Yiqi Su, JinJuan Yao, Maria Arcila, Farid Boulad, Hugo Castro-Malaspina, Christina Cho, Kevin J. Curran, Sergio Giralt, Nancy A. Kernan, Guenther Koehne, Ann Jakubowski, Esperanza Papadopoulos, Miguel-Angel Perales, Ioannis Politikos, Keith Price, Annamalai Selvakumar, Craig S. Sauter, Roni Tamari, Teresa Vizconde, James W. Young, Richard J. O’Reilly
Publikováno v: The Journal of Clinical Investigation, Vol 133, Iss 10 (2023)
Background Refractory CMV viremia and disease are associated with significant morbidity and mortality in recipients of hematopoietic stem cell transplant (HCT).Methods In phase I/II trials, we treated 67 subjects for CMV viremia or disease arising af
Externí odkaz: https://doaj.org/article/c8bff7f8a061422b8ccb6a5d37b43f5a
Zobrazit plný text záznamu
5
Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
Autor: Michael Scordo, Leah J. Gilbert, Danielle M. Hanley, Jessica R. Flynn, Sean M. Devlin, Linh K. Nguyen, Josel D. Ruiz, Gunjan L. Shah, Craig S. Sauter, David J. Chung, Heather J. Landau, Oscar B. Lahoud, Richard J. Lin, Parastoo B. Dahi, Miguel-Angel Perales, Sergio A. Giralt, Gerald A. Soff
Publikováno v: Blood Advances. 7:1536-1544
There are no standard treatments to prevent or hasten the recovery from severe conditioning-regimen–induced thrombocytopenia occurring after autologous hematopoietic cell transplantation (auto-HCT). We conducted an open-label, single-arm pilot stud
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e244dffe40a0b1da09124d3c7ed78c3
https://doi.org/10.1182/bloodadvances.2022007838
Zobrazit plný text záznamu
7
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation
Autor: Mariam T. Nawas, Miriam Sanchez-Escamilla, Sean M. Devlin, Molly A. Maloy, Josel D. Ruiz, Craig S. Sauter, Sergio A. Giralt, Miguel-Angel Perales, Michael Scordo
Publikováno v: Blood Advances. 6:5898-5907
Endothelial activation and stress index (EASIX) predicts nonrelapse mortality (NRM) when assessed before hematopoietic cell transplantation (HCT). We sought to determine whether changes in EASIX after HCT may be an informative marker of NRM. We evalu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc76cfd079ebe9feaa3ad0dc27dd8a43
https://doi.org/10.1182/bloodadvances.2022007381
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje